Kintor Pharmaceutical Limited announced that Ms. Yan LU was appointed as an executive Director with effect from 31 January 2022, pursuant to rule 13.51(2) of the Listing Rules. Ms. LU was appointed as the Chief Financial Officer of the Group in December 2019 and a joint company secretary of the Company in November 2021. Ms. LU is primarily responsible for financial internal control, investor relations, public relations and treasury management of the Group.

Prior to joining the Group, Ms. LU has over 13 years of experience in investment banking business. Ms. LU joined GF Capital (Hong Kong) Limited in July 2018. The Board hereby announces that Mr. Gang LU ("Mr. LU") resigned as a non-executive Director with effect from 31 January 2022 due to pursuit of his personal commitments, pursuant to rule 13.51(2) of the Listing Rules.